Curative Locoregional Therapy following Objective Response to Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Shao YY, Chen SC, Rau KM, Lee TY, Chan SL, Liu K, Lai HC, George J, Gofton C, Putraveephong S, Feng YH, Lee MY, Lee JX, Tai D, Lee SY, Chen YH, Wu TC, Mo LR, Wi WZ, Lesmana CRA, Hui CV, Li SSS, Hasan I, Chan LL, Nguyen M, De Silva M, Chuang CH
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.